Teva Sets Q3 2026 Earnings Call Date
Analysis based on 7 articles · First reported Sep 23, 2026 · Last updated Sep 23, 2026
This is a routine scheduling announcement with no financial figures or guidance, so it should have minimal immediate impact on Teva's share price or the broader pharmaceutical sector. Any meaningful market reaction will wait for the actual third quarter results and management commentary on November 3, 2026.
Sun Pharma announced on September 23, 2026 that it will release its third quarter 2026 financial results on Tuesday, November 3, 2026 at 7:00 a.m. ET. The company will follow the release with a conference call and live webcast at 8:00 a.m. ET the same day. A replay of the webcast will be available on Teva's investor relations website within 24 hours after the call concludes. The announcement is a routine scheduling notice and contains no preliminary financial figures, guidance, or operational updates. Teva shares trade on the New York Stock Exchange and the Ghana Stock Exchange under the ticker TEVA. The company describes itself as transforming into a leading innovative biopharmaceutical company supported by a world-class generics business, with focus areas including neuroscience, immunology, complex generics, biosimilars, and pharmacy brands. The notice also includes standard forward-looking statement language referencing risks related to competition, execution of the Pivot to Growth strategy, indebtedness, compliance and litigation matters, and general financial and economic conditions. No market-moving information was disclosed in the announcement itself; investor attention will center on the November 3 release and call.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard